Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia
Public ClinicalTrials.gov record NCT00968851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-Blind Placebo-Controlled 12-Week Phase 2 Study of Two Different Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist(EVP-6124)or Placebo in Schizophrenia Subjects on Chronic Stable Atypical Anti-Psychotic Therapy
Study identification
- NCT ID
- NCT00968851
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- FORUM Pharmaceuticals Inc
- Industry
- Enrollment
- 317 participants
Conditions and interventions
Interventions
- EVP-6124 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Dec 31, 2010
- Completion
- Feb 28, 2011
- Last update posted
- Apr 24, 2014
2009 – 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Intergrated Medical and Behavioral Associates | Glendale | California | 91204 | — |
| Excell Research | Oceanside | California | 92056 | — |
| University of California, San Diego | San Diego | California | 92103 | — |
| Affiliated Research Institute | San Diego | California | 92108 | — |
| Schuster Medical Research Institute | Sherman Oaks | California | 91403 | — |
| Scientific Clinical Research, Inc. | North Miami | Florida | 33161 | — |
| Uptown Research Institute | Chicago | Illinois | 60640 | — |
| Alexian Brothers Behavioral Health | Hoffman Estates | Illinois | 60169 | — |
| CBH Health, LLC | Rockville | Maryland | 20850 | — |
| CRI Worldwide | Willingboro | New Jersey | 20850 | — |
| Carolina Clinical Trials, Inc. | Charleston | South Carolina | 29407 | — |
| Vanderbilt Psychiatric Hospital | Nashville | Tennessee | 37212-8645 | — |
| FutureSearch Clinical Trials, L.P. | Austin | Texas | 78756 | — |
| InSite Clinical Research | DeSoto | Texas | 75115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00968851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00968851 live on ClinicalTrials.gov.